Ming Chen Selected Research

emamectin

7/2020

Research on allergic rhinitis improvement in asthmatic children after dust mite exposure reduction: a randomized, double-blind, cross-placebo study protocol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming Chen Research Topics

Disease

318	Neoplasms (Cancer) 05/2024 - 02/2002
68	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 01/2003
67	Inflammation (Inflammations) 02/2024 - 08/2004
58	Neoplasm Metastasis (Metastasis) 04/2024 - 08/2004
49	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 02/2002
44	Infections 03/2024 - 01/2002
36	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2007
28	Hypoxia (Hypoxemia) 02/2024 - 10/2002
27	Renal Cell Carcinoma (Grawitz Tumor) 08/2023 - 10/2010
26	Lung Neoplasms (Lung Cancer) 02/2024 - 03/2009
25	Hepatocellular Carcinoma (Hepatoma) 06/2023 - 01/2013
25	Carcinogenesis 01/2023 - 03/2005
23	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2024 - 10/2008
20	Hypertension (High Blood Pressure) 04/2023 - 10/2004
19	Nasopharyngeal Carcinoma 01/2023 - 10/2004
17	Fibrosis (Cirrhosis) 02/2024 - 12/2007
17	Myocardial Infarction 01/2024 - 01/2009
16	Asthma (Bronchial Asthma) 03/2024 - 08/2006
16	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 12/2010
15	Carcinoma (Carcinomatosis) 10/2023 - 05/2004
15	Pneumonia (Pneumonitis) 09/2023 - 10/2008
15	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 12/2002
15	Sepsis (Septicemia) 01/2023 - 01/2012
14	Hemorrhage 10/2023 - 09/2011
14	Thrombosis (Thrombus) 10/2023 - 06/2003
13	Obesity 04/2024 - 12/2004
13	Urinary Bladder Neoplasms (Bladder Cancer) 03/2024 - 07/2017
13	Osteoporosis 03/2024 - 01/2020
13	Wounds and Injuries (Trauma) 02/2024 - 05/2003
13	Stomach Neoplasms (Stomach Cancer) 01/2024 - 04/2011
12	Melanoma (Melanoma, Malignant) 04/2024 - 05/2009
12	COVID-19 12/2023 - 01/2020
12	Shock 04/2022 - 12/2003
11	Kidney Calculi (Kidney Stone) 03/2024 - 05/2015
11	Pain (Aches) 11/2023 - 02/2003
11	Erectile Dysfunction 08/2023 - 10/2003
11	Dehydration (Water Stress) 01/2022 - 02/2007
10	Lymphatic Metastasis 02/2024 - 09/2004
10	Chronic Renal Insufficiency 02/2024 - 09/2019
9	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 11/2012
9	Glioblastoma (Glioblastoma Multiforme) 03/2024 - 08/2021
9	Body Weight (Weight, Body) 02/2024 - 01/2009
9	Edema (Dropsy) 01/2024 - 02/2006
9	Ischemia 09/2023 - 01/2007
9	Tuberculosis (Tuberculoses) 04/2022 - 09/2011
9	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 08/2015
9	Airway Remodeling 10/2020 - 10/2008
9	Cataract (Cataracts) 01/2019 - 01/2007
8	Heart Failure 04/2024 - 06/2010
8	Glioma (Gliomas) 04/2024 - 05/2009

Drug/Important Bio-Agent (IBA)

105	Proteins (Proteins, Gene)FDA Link 05/2024 - 12/2002
79	Biomarkers (Surrogate Marker)IBA 04/2024 - 09/2004
49	MicroRNAs (MicroRNA)IBA 05/2024 - 05/2013
31	RNA (Ribonucleic Acid)IBA 04/2024 - 05/2014
31	Messenger RNA (mRNA)IBA 01/2024 - 11/2005
29	Long Noncoding RNAIBA 01/2024 - 12/2016
22	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 03/2007
22	Therapeutic UsesIBA 03/2024 - 09/2009
20	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 03/2002
20	CytokinesIBA 03/2024 - 08/2006
19	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 01/2007
18	LipidsIBA 02/2024 - 07/2015
15	Indicators and Reagents (Reagents)IBA 10/2023 - 04/2010
14	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2009
13	Small Interfering RNA (siRNA)IBA 07/2023 - 11/2005
12	AntioxidantsIBA 04/2024 - 05/2003
12	AntibodiesIBA 04/2024 - 09/2011
12	AndrogensIBA 01/2024 - 01/2011
11	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 04/2008
11	Circular RNAIBA 12/2022 - 01/2019
10	Interleukin-6 (Interleukin 6)IBA 03/2024 - 05/2007
10	CateninsIBA 01/2024 - 01/2013
10	CollagenIBA 11/2023 - 01/2011
10	EnzymesIBA 11/2023 - 01/2013
10	AntigensIBA 01/2023 - 09/2011
9	PlatinumIBA 04/2024 - 11/2015
9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 07/2017
9	Hormones (Hormone)IBA 01/2024 - 01/2010
9	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2023 - 04/2010
9	ElementsIBA 01/2022 - 02/2007
9	Genetic Markers (Genetic Marker)IBA 08/2017 - 12/2010
8	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2019
8	Phosphotransferases (Kinase)IBA 03/2024 - 01/2009

Therapy/Procedure

131	Therapeutics 05/2024 - 12/2002
74	Radiotherapy 04/2024 - 02/2002
49	Drug Therapy (Chemotherapy) 04/2024 - 12/2002
29	Chemoradiotherapy 03/2024 - 10/2006
25	Immunotherapy 04/2024 - 01/2014
18	Castration 01/2024 - 08/2012
15	Aftercare (After-Treatment) 02/2024 - 09/2010
13	Nephrectomy 01/2022 - 10/2010
11	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2024 - 09/2016
11	Ligation 02/2024 - 01/2009
11	Neoadjuvant Therapy 01/2024 - 03/2005
10	Stents 01/2024 - 11/2009
9	Transplantation 10/2023 - 11/2013
9	Prostatectomy (Retropubic Prostatectomy) 04/2023 - 10/2015
9	Length of Stay 09/2022 - 10/2015
8	Cystectomy 03/2024 - 07/2010
8	Punctures 02/2024 - 10/2019